InvestSMART

4DMedical Limited (ASX: 4DX) - Announcements

Current share price for 4DX : $3.540 0.1 (2.91%)+

ASX company news and announcements for 4DMedical Limited (4DX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All 4DMedical Limited (4DX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than 4DMedical Limited (4DX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for 4DMedical Limited (4DX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$2,130 Notification regarding unquoted securities - 4DX 11 Oct 2024 2:14PM $0.570 $3.540 risen by 521.05%
$2,130 Investor Presentation - Philips update 1 Oct 2024 9:37AM $0.675 $3.540 risen by 424.44%
$2,130 Investor briefing - Philips update 30 Sep 2024 9:32AM $0.630 $3.540 risen by 461.90%
$2,130 Appendix 4G 30 Sep 2024 9:25AM $0.630 $3.540 risen by 461.90%
$2,130 Corporate Governance Statement 30 Sep 2024 9:24AM $0.630 $3.540 risen by 461.90%
$2,130 Annual Report 30 Sep 2024 9:24AM $0.630 $3.540 risen by 461.90%
$2,130 4DMedical signs Philips reseller agreement for U.S. market 27 Sep 2024 9:03AM $0.445 $3.540 risen by 695.51%
$2,130 Notice of AGM Date 24 Sep 2024 11:41AM $0.450 $3.540 risen by 686.67%
$2,130 FY2024 Full year results 30 Aug 2024 9:19AM $0.415 $3.540 risen by 753.01%
$2,130 Appendix 4E - Preliminary Final Report 30 Aug 2024 9:18AM $0.415 $3.540 risen by 753.01%
$2,130 Expiry of options and Appendix 3Y 14 Aug 2024 3:21PM $0.455 $3.540 risen by 678.02%
$2,130 Notification of cessation of securities - 4DX 14 Aug 2024 3:11PM $0.445 $3.540 risen by 695.51%
$2,130 Application for quotation of securities - 4DX 2 Aug 2024 2:55PM $0.495 $3.540 risen by 615.15%
$2,130 Quarterly Activity Report and Appendix 4C for Q4 FY2024 31 Jul 2024 9:15AM $0.510 $3.540 risen by 594.12%
$2,130 Application for quotation of securities - 4DX 11 Jul 2024 3:10PM $0.525 $3.540 risen by 574.29%
$2,130 4DMedical expands with Jones Radiology contract 8 Jul 2024 9:35AM n/a $3.540 n/a
$2,130 Cleansing Notice 28 Jun 2024 9:37AM $0.570 $3.540 risen by 521.05%
$2,130 Application for quotation of securities - 4DX 28 Jun 2024 9:34AM $0.570 $3.540 risen by 521.05%
$2,130 4DMedical secures At-the-Market funding facility 28 Jun 2024 9:31AM $0.570 $3.540 risen by 521.05%
$2,130 Application for quotation of securities - 4DX 21 Jun 2024 2:29PM $0.590 $3.540 risen by 500%
$2,130 Market update on recent developments 9 May 2024 3:44PM $0.560 $3.540 risen by 532.14%
$2,130 4DMedical gains US CMS reimbursement for CT LVAS 9 May 2024 10:02AM $0.560 $3.540 risen by 532.14%
$2,130 4DMedical signs research agreement with West Los Angeles VA 7 May 2024 8:55AM $0.575 $3.540 risen by 515.65%
$2,130 Application for quotation of securities - 4DX 3 May 2024 2:34PM $0.600 $3.540 risen by 490%
$2,130 Quarterly Activity Report and Appendix 4C for Q3 FY2024 30 Apr 2024 9:59AM $0.615 $3.540 risen by 475.61%

276 - 300 of 596 results

Page 12 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.